A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis (Q65375969)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis |
clinical trial |
Statements
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (English)
0 references
2 March 2011
0 references
23 July 2015
0 references
732
0 references
18 year
0 references
55 year
0 references